Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents

Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents

Schizophrenia is a chronic mental illness, which remains difficult to treat. A high resistance to the available therapies, their insufficient efficacy, and numerous side effects are the reasons why there is an urgent need to develop new antipsychotics. This study aimed to assess the antipsychotic-li...

Full description

Bibliographic Details
Main Authors:	Elżbieta Żmudzka, Klaudia Lustyk, Monika Głuch-Lutwin, Barbara Mordyl, Alicja Zakrzewska-Sito, Paweł Mierzejewski, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	International Journal of Molecular Sciences
Subjects:	antipsychotic-like activity anxiolytic-like effect D<sub>2</sub> receptor antagonist 5-HT<sub>1A</sub> receptor antagonist arylpiperazine derivative of salicylamide
Online Access:	https://www.mdpi.com/1422-0067/23/24/15929

Similar Items

Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice
by: Elżbieta Żmudzka, et al.
Published: (2023-01-01)

Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice
by: Elżbieta Żmudzka, et al.
Published: (2023-03-01)

Xanthine–Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases
by: Michał Załuski, et al.
Published: (2023-07-01)

Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT<sub>1A</sub> and D<sub>2</sub> Receptors
by: Kinga Sałaciak, et al.
Published: (2021-07-01)

Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties
by: Vittorio Canale, et al.
Published: (2021-06-01)

Anxiolytic-like activity of serotonin-3 receptor antagonist: In-silico molecular modeling, drug-likeness and evaluation of anxiolytic activity
by: Venkatesha Perumal Ramachandran, et al.
Published: (2022-06-01)

Design, Synthesis and 5-HT<sub>1A</sub> Binding Affinity of <i>N</i>-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)tricyclo[3.3.1.1<sup>3,7</sup>]decan-1-amine and <i>N</i>-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)-3,5-dimethyl-tricylo[3.3.1.1<sup>3,7</sup>]decan-1-amine
by: Grigoris Zoidis, et al.
Published: (2022-03-01)

Novel Arylpiperazine Derivatives of Salicylamide with α<sub>1</sub>-Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats
by: Elżbieta Żmudzka, et al.
Published: (2022-12-01)

Drug Repositioning of the α<sub>1</sub>-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?
by: Romane Florent, et al.
Published: (2020-07-01)

New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics Simulations
by: Giovanni Bolcato, et al.
Published: (2020-05-01)

The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice
by: Nermin Eissa, et al.
Published: (2021-02-01)

A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
by: Andrea Spinaci, et al.
Published: (2022-01-01)

<i>N</i>-Skatyltryptamines—Dual 5-HT<sub>6</sub>R/D<sub>2</sub>R Ligands with Antipsychotic and Procognitive Potential
by: Agata Hogendorf, et al.
Published: (2021-07-01)

Solvates of New Arylpiperazine Salicylamide Derivative-a Multi-Technique Approach to the Description of 5 HTR Ligand Structure and Interactions
by: Edyta Pindelska, et al.
Published: (2021-05-01)

Design and Synthesis of 2,6-Disubstituted-4′-Selenoadenosine-5′-<em>N</em>,<em>N</em>-Dimethyluronamide Derivatives as Human A<sub>3</sub> Adenosine Receptor Antagonists
by: Hongseok Choi, et al.
Published: (2021-04-01)

Extended N-Arylsulfonylindoles as 5-HT6 Receptor Antagonists: Design, Synthesis & Biological Evaluation
by: Gonzalo Vera, et al.
Published: (2016-08-01)

Pathophysiological Role and Medicinal Chemistry of A<sub>2A</sub> Adenosine Receptor Antagonists in Alzheimer’s Disease
by: Stefania Merighi, et al.
Published: (2022-04-01)

Antiplatelet Effects of Selected Xanthine-Based Adenosine A<sub>2A</sub> and A<sub>2B</sub> Receptor Antagonists Determined in Rat Blood
by: Monika Kubacka, et al.
Published: (2023-08-01)

Allosteric Antagonism of the A<sub>2A</sub> Adenosine Receptor by a Series of Bitopic Ligands
by: Zhan-Guo Gao, et al.
Published: (2020-05-01)

Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders
by: Ramakrishna Nirogi, et al.
Published: (2023-02-01)

Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
by: Taryn Bosquez-Berger, et al.
Published: (2023-08-01)

Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y<sub>12</sub> Antagonists in a cAMP- and Calcium-Dependent Manner
by: Nina Wolska, et al.
Published: (2020-07-01)

Adenosine Receptor Agonists Exhibit Anti-Platelet Effects and the Potential to Overcome Resistance to P2Y<sub>12</sub> Receptor Antagonists
by: Nina Wolska, et al.
Published: (2019-12-01)

Microwave-Assisted Synthesis of Trazodone and Its Derivatives as New 5-HT<sub>1A</sub> Ligands: Binding and Docking Studies
by: Jolanta Jaśkowska, et al.
Published: (2019-04-01)

Guanidines: Synthesis of Novel Histamine H<sub>3</sub>R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect
by: Marek Staszewski, et al.
Published: (2023-04-01)

Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus
by: Rosa Sparaco, et al.
Published: (2022-10-01)

Evaluation of Some Safety Parameters of Dual Histamine H<sub>3</sub> and Sigma-2 Receptor Ligands with Anti-Obesity Potential
by: Kamil Mika, et al.
Published: (2023-04-01)

The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia
by: Klaudia Lustyk, et al.
Published: (2021-10-01)

PAC<sub>1</sub>, VPAC<sub>1</sub>, and VPAC<sub>2</sub> Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies
by: Zoe Tasma, et al.
Published: (2022-11-01)

The Novel Pimavanserin Derivative ST-2300 with Histamine H<sub>3</sub> Receptor Affinity Shows Reduced 5-HT<sub>2A</sub> Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in Mice
by: Karthikkumar Venkatachalam, et al.
Published: (2022-05-01)

Monoamine Oxidase Inhibition by Major Tanshinones from <i>Salvia miltiorrhiza</i> and Selective Muscarinic Acetylcholine M<sub>4</sub> Receptor Antagonism by Tanshinone I
by: Ritu Prajapati, et al.
Published: (2021-07-01)

Mind the Gap: Model-Based Switching from Selatogrel to Maintenance Therapy with Oral P2Y12 Receptor Antagonists
by: Chih-hsuan Hsin, et al.
Published: (2023-09-01)

Design and Synthesis of Conformationally Flexible Scaffold as Bitopic Ligands for Potent D<sub>3</sub>-Selective Antagonists
by: Ho Young Kim, et al.
Published: (2022-12-01)

Involvement of P2Y<sub>1</sub>, P2Y<sub>6</sub>, A<sub>1</sub> and A<sub>2A</sub> Receptors in the Purinergic Inhibition of NMDA-Evoked Noradrenaline Release in the Rat Brain Cortex
by: Clara Quintas, et al.
Published: (2023-06-01)

Identification of a Novel Neuropeptide S Receptor Antagonist Scaffold Based on the SHA-68 Core
by: Allison Zarkin, et al.
Published: (2021-10-01)

Antagonizing S1P<sub>3</sub> Receptor with Cell-Penetrating Pepducins in Skeletal Muscle Fibrosis
by: Angela Corvino, et al.
Published: (2021-08-01)

Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice
by: Magdalena Kotańska, et al.
Published: (2022-11-01)

The AT<sub>1</sub>/AT<sub>2</sub> Receptor Equilibrium Is a Cornerstone of the Regulation of the Renin Angiotensin System beyond the Cardiovascular System
by: Mélissa Colin, et al.
Published: (2023-07-01)

The Commensal Microbiota Enhances ADP-Triggered Integrin α<sub>IIb</sub>β<sub>3</sub> Activation and von Willebrand Factor-Mediated Platelet Deposition to Type I Collagen
by: Klytaimnistra Kiouptsi, et al.
Published: (2020-09-01)

Pharmacotherapy treatment principles for insomnia
by: S. V. Okovityi, et al.
Published: (2018-04-01)